Kairos Pharma Ltd. (KAPA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Kairos Pharma Ltd.

    AMEX: KAPA · Real-Time Price · USD
    1.35
    0.09 (7.14%)
    At close: Aug 29, 2025, 3:59 PM
    1.43
    5.53%
    After-hours: Aug 29, 2025, 07:58 PM EDT

    Kairos Pharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -2.6M -1.81M -1.05M -2.15M
    Depreciation & Amortization
    		 160K 160K 160K 98K
    Stock-Based Compensation
    		 218K 913K n/a 300K
    Other Working Capital
    		 -1.98M 764K 129K 1.19M
    Other Non-Cash Items
    		 254K 56K 408K 144K
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -1.98M 764K 129K 1.19M
    Operating Cash Flow
    		 -3.96M 81K -353K -412K
    Capital Expenditures
    		 n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a -109K
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a -109K
    Debt Repayment
    		 n/a n/a 895K 330K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -390K n/a -121K n/a
    Financial Cash Flow
    		 5.13M -425K 717K 580K
    Net Cash Flow
    		 1.18M -344K 364K 59K
    Free Cash Flow
    		 -3.96M 81K -353K -412K

    Add to Watchlist